Some aggressive cancer subtypes, such as basal‐like PDAC, display reduced dependence on KRAS and heightened reliance on YAP/TAZ activity, often driven by Src family kinase (SFK) signaling [93]. The gene discussed is KRAS; the disease is cancer.